Section Arrow
Quote
BLCO.NYSE
- Bausch + Lomb Corp
Quotes are at least 15-min delayed:2025/07/07 00:54 EDT
Last
 13.88
+0.12 (+0.87%)
Day High 
13.965 
Prev. Close
13.76 
1-M High
13.78 
Volume 
618.72K 
Bid
12.81
Ask
13.95
Day Low
13.68 
Open
13.7 
1-M Low
11.22 
Market Cap 
4.86B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 12.42 
20-SMA 12.23 
50-SMA 12.03 
52-W High 21.69 
52-W Low 10.45 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-1.02/1.08
Enterprise Value
9.61B
Balance Sheet
Book Value Per Share
18.00
Cash Flow
Cash Flow Yield
0.03
Income Statement
Total Revenue
4.79B
Operating Revenue Per Share
11.23
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
AVTRAvantor13.88-0.01-0.07%13.36PE
MBOTMicrobot Medical2.6+0.1+4.00%-- 
ALCAlcon87.78-1.52-1.70%39.69PE
XRAYDENTSPLY SIRONA16.67+0.1+0.60%-- 
COOCooper Companies (The)73.3+0.28+0.38%35.28PE
Quotes are at least 15-min delayed：2025/07/07 00:54 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.